Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2025-12-24 @ 11:46 AM
NCT ID:
NCT02551861
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
* Genotype 3
* HCV RNA \< 2000000 IU/mL
* Never taken HCV medication
* Absence of advanced fibrosis or cirrhosis
* Body mass index (BMI) 18-40 kg/m\^2
Exclusion Criteria:
* Infection with HCV other than genotype 3 (GT3); Mixed infections of any genotype
* Previously taken HCV medication
* Liver Cirrhosis
* Evidence of decompensated liver disease
* HIV/ hepatitis B virus (HBV) coinfection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02551861
Study Brief:
Protocol Section:
NCT02551861